Christopher Chapple

No bio available.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Health Publishing (General Urology)
    Ineligible company: 
    Astellas
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (General Urology)
    Ineligible company: 
    Allergan
  • Attribution: 
    Self
    Type of financial relationship: 
    Scientific Study or Trial (General Urology)
    Ineligible company: 
    Allergan
  • Attribution: 
    Self
    Type of financial relationship: 
    Meeting Participant or Lecturer (General Urology)
    Ineligible company: 
    Allergan
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (General Urology)
    Ineligible company: 
    Contura
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (General Urology)
    Ineligible company: 
    Pierre Fabre
  • Attribution: 
    Self
    Type of financial relationship: 
    Meeting Participant or Lecturer (General Urology)
    Ineligible company: 
    Luoin Pharma
  • Attribution: 
    Self
    Type of financial relationship: 
    Leadership Position (General Urology)
    Ineligible company: 
    European Association of Urology
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (General Urology)
    Ineligible company: 
    Urovant Sciences
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (General Urology)
    Ineligible company: 
    Symimetics

Pages

Return to Contemporary Pharmacotherapy for OAB 2022: Monotherapy and Combined Pharmacotherapy to Optimize Treatment Webcast (2022)